Advancements in Targeted Therapies for Infectious Diseases

Image credit: Volodymyr Hryshchenko, Unsplash Infectious diseases remain a major global health threat, with bacteria, viruses, fungi, and parasites evolving resistance to conventional treatments. Antibiotics, antivirals, and antifungals have saved millions of lives, but the growing challenge of antimicrobial resistance (AMR) demands precise, innovative, and highly targeted therapies.1 Instead of traditional broad-spectrum drugs, researchers are … Read more

Top 5 Infectious Disease News Stories Week of February 1-8

Children with Invasive Candidiasis Do Well After Switching IV Antifungal to Enteral A study on children with invasive candidiasis found that transitioning from intravenous (IV) antifungal treatment to enteral therapy was as effective as completing the full IV course, with 99% of those who transitioned having successful treatment outcomes. The shift to enteral therapy reduced … Read more

Study Links Genetic Variations in Cryptococcus neoformans to Disease Outcomes

A study published in Nature Communications has revealed how genetic variations within Cryptococcus neoformans, the pathogen responsible for cryptococcal meningitis, impact patient outcomes. Using a mouse model, the researchers focused on the sequence type 93 (ST93) clade, which includes two subpopulations: ST93A and ST93B. The findings highlight how genetic differences between these subpopulations influence virulence … Read more

Harnessing the Power of AI in the Fight Against Antimicrobial Resistance

Image credit: Tara Winstead, Pexels Much of the conversations around artificial intelligence (AI) as of late has been in the realm of what are the promise and perils it could bring. Can it increase the risk of bioterrorism or help us combat disease?1 In the midst of this, sits the growing threat of antimicrobial resistance … Read more

Transitioning Antifungal Therapy from IV to Enteral in Pediatric Invasive Candidiasis: PEACE Study Findings

Transitioning Antifungal Therapy from IV to Enteral for Pediatric Invasive Candidiasis: A Breakthrough Study Dr. Robert F. T. Bucayu, MD, MPH, and his team have conducted a groundbreaking… The post Transitioning Antifungal Therapy from IV to Enteral in Pediatric Invasive Candidiasis: PEACE Study Findings appeared first on NewsyList. Source link

Top 5 Infectious Disease News Stories Week of January 25-February 1

State of Kansas Reports Country’s Largest Tuberculosis Outbreak A tuberculosis (TB) outbreak is currently affecting Wyandotte and Johnson counties in Kansas, with 60 active cases in Wyandotte County and 7 in Johnson County as of January 24. Additionally, 77 latent TB infections have been reported in Wyandotte County and 2 in Johnson County since 2024. … Read more

Novel Compound Demonstrates Activity Against Vancomycin-Resistant Enterococci

Professor Takeshi Murata, Graduate School of Science, Chiba University Image credit: Chiba University Vancomycin-Resistant Enterococcus (VRE) is an opportunistic pathogen thatcan causes severe hospital-acquired bacterial infections like endocarditis and sepsis and has developed resistance to multiple antibiotics.1 Inpatients at risk for VRE infections include those who are immunocompromised; those who have taken vancomycin and other … Read more

The Top 5 Infectious Disease News Stories Week of January 18-25

Fungal Infections: Invisible Until It’s Too Late Fungal infections impact over 1 billion people globally each year, leading to millions of life-threatening cases and deaths. In response to this under-recognized health threat, the Global Action Fund for Fungal Infections (GAFFI) launched the “95-95 by 2025” initiative, aiming to diagnose and treat 95% of serious fungal … Read more

Debating the Value of Incorporating Antibiotic Stewardship Principles Into Infection Guidelines

Over the years, we have seen the emergence of antibiotic resistance become a major global health concern. When compared against high mortality rates that occur annually from cancer (8.2 million) or diabetes (1.5 million), we see antibiotic-resistant infections account for approximately 700,000 deaths each year (FIGURE).1 It is estimated that the number of deaths resulting … Read more

Genetic Mutations of Avian Influenza Emerge in First Severe US Case

The Centers for Disease Control and Prevention (CDC) is reporting that the patient identified with the first severe case of the avian influenza A(H5N1) in the US has differing mutations from previous cases in the country and strongly suggests that the changes emerged during infection as virus replicated in the patient.1 Although the CDC writes … Read more